Yong Yi Wu

R&D Manager
BioGend Therapeutics Co., Ltd.

​​

Mr. Yong Yi Wu obtained his bachelor’s and master’s degrees in chemical engineering from National Tsing Hua University in Taiwan. He has been involved in the biomedical industry for more than 15 years. He is currently the manager of the R&D department of BioGend Therapeutics Co., Ltd., responsible for the development of medical equipment products for cell therapy and orthopedic surgery instruments, and is committed to helping BioGend become a comprehensive medical care expert.

Company Profile

The SoufCut Autologous Adipose Precursor Cell Collection System is a sterile medical device designed to collect Stromal Vascular Fraction Cells (SVF cells) from adipose tissue. By simply taking a 10-gram excision fat from the body and putting it into the kit, up to 10 to the power of 7 cells can be obtained. The entire process can be completed in just one hour, and it can help with difficult wound healing such as diabetic foot ulcers, slow down the pain of degenerative arthritis, and extend the maintenance time of adipose tissue in the field of medical beauty.
​